Who owns CASI PHARMACEUTICALS INC?
- Ticker: CASI
- CUSIP Number: g1933s101
Tip: Access positions for across all investors
Analyze quarterly positions in Casi Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Casi Pharmaceuticals stock
Who bought or sold CASI PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| VR Adviser | 987k | $839k | 0% | Dec 2025 |
|
| Woodline Partners | 133k | $113k | -19% | Dec 2025 |
|
| Renaissance Technologies | 43k | $37k | -2% | Dec 2025 |
|
| Two Sigma Investments | 33k | $55k | 100% | Sep 2025 |
|
| Geode Capital Management | 19k | $16k | 0% | Dec 2025 |
|
| Royal Bank of Canada | 10k | $0 | 0% | Sep 2025 |
|
| UBS Group | 659.00 | $560.018200 | 4607% | Dec 2025 |
|
| Wells Fargo & Company | 505.00 | $428.997500 | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 134.00 | $113.993800 | 0% | Dec 2025 |
|
| Simplex Trading | 133.00 | $112.996800 | -8% | Dec 2025 |
|
| Jpmorgan Chase & Co | 25.00 | $42.000000 | 100% | Sep 2025 |
|
| Colonial Trust Co / SC | 11.00 | $9.000200 | 0% | Dec 2025 |
|
| MAI Wealth Advisors | 5.00 | $5.000000 | 0% | Dec 2025 |
|
Who sold out of Casi Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Foresite Capital Management VI | Sep 2025 | 980k | $1.6M |
| Wellington Shields Capital Management | Sep 2025 | 70k | $115k |
| Citadel Advisors | Jun 2025 | 36k | $43k |
| Wellington Shields & Co | Sep 2025 | 30k | $50k |
| Ground Swell Capital | Sep 2025 | 10k | $17k |
| Group One Trading | Sep 2025 | 2.3k | $3.8k |
| BlackRock | Sep 2025 | 296.00 | $491.004800 |
| Northwestern Mutual Wealth Management Company | Sep 2025 | 13.00 | $21.999900 |